Musaiwale Kamfose is a distinguished Clinical Researcher at Oxford University NHS Trust, where he has been instrumental in advancing the field of infectious diseases since March 2013. With a robust academic foundation, including a PhD in Health from the University of Bath and Oxford, as...
Musaiwale Kamfose is a distinguished Clinical Researcher at Oxford University NHS Trust, where he has been instrumental in advancing the field of infectious diseases since March 2013. With a robust academic foundation, including a PhD in Health from the University of Bath and Oxford, as well as a Master’s in Evidence-Based Medicine from Oxford University, Musaiwale combines rigorous scientific inquiry with practical application in clinical settings. His expertise is further bolstered by his training as a Global Clinical Scholar at Harvard University, equipping him with a global perspective on health challenges.
In his current role, Musaiwale leads the National Institute for Health Research (NIHR) portfolio studies focused on infectious diseases, overseeing a diverse array of research projects from their inception to successful completion. His pivotal contributions to COVID-19 research have not only enhanced understanding of the virus but also improved resource management within the trust. Musaiwale is adept at monitoring and assessing the progress of various studies, producing comprehensive reports that inform stakeholders and guide future research directions.
His skill set is extensive, encompassing critical care, clinical research, and healthcare management, alongside a strong proficiency in research ethics as a member of the Oxford Tropical Research Ethics Committee. With three years of experience in reviewing global research studies, Musaiwale is a high performer committed to upholding the highest ethical standards in clinical research. His dedication to advancing medical knowledge and improving patient outcomes positions him as a key figure in the ongoing fight against infectious diseases, making significant contributions to both the academic and clinical communities.
